After years of US-dollar dominance, it looks like cracks may be appearing in the Greenback. A weaker US dollar has historically served as a structural tailwind for emerging market (EM) equities.
But investing in EM is not for the faint of heart due to risks that can include political instability, social instability and regulatory uncertainty.
This article examines why US dollar weakness could act as a tailwind for emerging market equities, the equity valuations on offer in EM compared to developed market peers, and why China’s recent reform and stimulus could potentially spark a broader resurgence across the region.
A weaker US dollar has historically been positive for emerging markets. As the dollar declines, emerging market currencies tend to strengthen on a relative basis. Stronger EM currencies have several benefits:
In light of the above, it’s not surprising that there is a historical correlation between periods of US dollar weakness and improved performance of EM equities.
In Schroders’ view, should this trend of a softer US dollar continue, there is a case that EM equities could deliver relatively stronger returns over the coming period.
In Schroders’ view, from a valuation standpoint, emerging markets remain notably attractive when compared to their developed market counterparts.
US equities are currently trading at elevated forward price-to-earnings (P/E) ratios, reflecting both high expectations and increased risk of earnings disappointment.
In contrast, forward P/E ratios across emerging markets remain under 13 times, a significant discount to the nearly 20 times seen in developed markets [2].
Moreover, with recent developments such as the post-Liberation Day trend of capital repatriation, Schroders is starting to see international investors re-allocating capital back to their domestic markets. This has bolstered returns in Europe and may serve as a catalyst for renewed investment in EM.
A key development supporting EM equities is the wave of monetary and fiscal stimulus emanating from China. Policymakers there have already enacted interest rate cuts, providing a much-needed boost to domestic growth.
More recently, there is evidence to suggest that China is embarking on a long-anticipated programme of fiscal stimulus. Government bond issuance has picked up markedly since the fourth quarter of last year, resulting in a notable acceleration in China’s Total Social Financing measure—a broad gauge of credit and liquidity in the economy.
After several years of contraction, this renewed credit growth is supporting not only China’s domestic economy, but also potentially generating positive spill-over effects throughout the broader Asian region.
Recent political signals also indicate a material shift in China’s approach to private enterprise. Perhaps no act was more symbolic than President Xi Jinping’s highly publicised handshake with Jack Ma, the long-silenced CEO of Alibaba. For years, Ma’s absence from the public eye suggested that powerful private entrepreneurs were unwelcome or even seen as threats to the authority of the state.
This recent gesture, combined with announcements of policy changes aimed at levelling the playing field between state-owned enterprises and private companies, marks a notable reversal of the ‘common prosperity’ campaign that previously weighed on private sector returns and investor confidence.
President Xi Jinping has further communicated an explicit commitment to abolish unreasonable regulatory fees and fines imposed on private firms, directly encouraging entrepreneurs to invest and fuel China’s development.
In Schroders’ view, these changes could create a more favourable environment for equity markets, providing the potential for a re-rating of Chinese stocks.
China is home to several high-quality companies at the forefront of transformative technologies, including artificial intelligence. Yet, in Schroders’ view, valuations of leading Chinese tech companies are nowhere near the levels of multiple re-rating enjoyed by leading US technology names such as the so-called ‘Magnificent Seven.’
This divergence may be largely due to investors’ concerns over regulatory crackdowns and doubts about the investability of Chinese equities in recent years.
However, with the recent retreat from ‘common prosperity’ policies and a new commitment to supporting private business, these well-resourced and innovative companies are now more likely to see a re-rating reflecting their long-term growth prospects.
It is noteworthy that capital expenditure by these Chinese technology giants has ramped up significantly over the past year, after a prolonged period of relative restraint – an encouraging sign that long-term investments and future growth platforms are already in development within the sector.
Despite the positive factors outlined above, there remain significant risks to the outlook for the Chinese economy and its equity market, which could have flow on impacts to the broader emerging market index.
While the overall growth picture in China remains healthy, the composition of that growth remains imbalanced, with fixed asset investment remaining benign, and activity in the Chinese property sector remaining weak, with both real estate sales and housing starts at multi-year lows, despite a significant easing of monetary policy over the last few years.
This has meant that overall Chinese economic growth is becoming more reliant on fiscal policy, rather than the private sector, where demand for credit remains weak.
Beyond the domestic picture, trade uncertainty and tariffs still linger as a significant ongoing risk for China and emerging markets more broadly.
At the time of writing, it appears that President Trump is once again threatening to impose tariffs on a number of countries, even in the case of Vietnam, where a trade deal looked to have been announced. [In June and July, the US announced trade deals or in-principle trade agreements with Japan, the United Kingdom and Indonesia and the European Union.]
While China, so far appears to have been spared [in the latest tariff threats], the risk of a re-escalation in trade tensions, which could potentially bring elevated volatility and downside risks back to financial markets, remains a source of uncertainty to emerging markets.
[All emerging markets have individual country-specific and market risks. Do further research of your own or talk to a licensed financial adviser to understand the features, benefits and risks of investing in emerging markets beyond China, such as India, Brazil, Indonesia and Russia. These markets may have higher regulatory, security and currency risks than advanced economies].
If the US dollar continues to weaken, emerging markets may stand to benefit. Renewed currency strength gives emerging market central banks space to stimulate their economies via more accommodative interest rate settings. In Schroders’ opinion, attractive starting equity valuations in EM add to this appeal.
Crucially, China’s decisive shift in policy - marked by robust fiscal stimulus and a revival of private enterprise – may add momentum to this narrative, with positive spill-over effects possible across the broader Asian region.
In Schroders’ view, while active management will be key to navigating ongoing risks in EM, the case for including EM assets as part of a diversified, long-term strategy is strengthening.
-----------------------
[1] J.P. Morgan Mid-Year Outlook 2025. EM Equity Strategy.
[2] MSCI Emerging Markets Index (USD) as at June 30, 2025.
DISCLAIMER
Issued by Schroder Investment Management Australia Limited.
This document does not contain and should not be taken as containing any financial product advice or financial product recommendations. This document does not take into consideration any recipient’s objectives, financial situation or needs. Before making any decision relating to a Schroders fund, you should obtain and read a copy of the product disclosure statement available at www.schroders.com.au or other relevant disclosure document for that fund and consider the appropriateness of the fund to your objectives, financial situation and needs. You should also refer to the target market determination for the fund at www.schroders.com.au. All investments carry risk, and the repayment of capital and performance in any of the funds named in this document are not guaranteed by Schroders or any company in the Schroders Group. The material contained in this document is not intended to provide, and should not be relied on for accounting, legal or tax advice.
Schroders does not give any warranty as to the accuracy, reliability or completeness of information which is contained in this document. To the maximum extent permitted by law, Schroders, every company in the Schroders plc group, and their respective directors, officers, employees, consultants and agents exclude all liability (however arising) for any direct or indirect loss or damage that may be suffered by the recipient or any other person in connection with this document.
Opinions, estimates and projections contained in this document reflect the opinions of the authors as at the date of this document and are subject to change without notice. “Forward-looking” information, such as forecasts or projections, are not guarantees of any future performance and there is no assurance that any forecast or projection will be realised. Past performance is not a reliable indicator of future performance. All references to securities, sectors, regions and/or countries are made for illustrative purposes only and are not to be construed as recommendations to buy, sell or hold.
Telephone calls and other electronic communications with Schroders representatives may be recorded.
Don’t miss the latest insights from ASX Investor Update on LinkedIn
The views, opinions or recommendations of the author in this article are solely those of the author and do not in any way reflect the views, opinions, recommendations, of ASX Limited ABN 98 008 624 691 and its related bodies corporate (“ASX”). ASX makes no representation or warranty with respect to the accuracy, completeness or currency of the content. The content is for educational purposes only and does not constitute financial advice. Independent advice should be obtained from an Australian financial services licensee before making investment decisions. To the extent permitted by law, ASX excludes all liability for any loss or damage arising in any way due to or in connection with the publication of this article, including by way of negligence.